Cepheid to Webcast Upcoming Financial Presentations

Published on Wednesday, 01 February 2012 16:30 Written by TradersHuddle Staff

SUNNYVALE, Calif., Feb. 1, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.

Leerink Swann Global Healthcare Conference, New York, NY

Wednesday, February 15, 2012 at 11.30 a.m. Eastern Time

Raymond James Annual Conference, Orlando, FL

Tuesday, March 6, 2012 at 1.05 p.m. Eastern Time

Additionally, Cepheid announced that it will participate in The NASDAQ Opening Bell ceremony at The NASDAQ Stock Market on Tuesday, February 7, 2012. The ceremony commemorates the continued growth and innovation of Cepheid's GeneXpert® system which saw record placements in 2011, and will take place at 9:30 a.m. Eastern Time at The NASDAQ MarketSite Studio in Times Square, New York City.

Accessing Live Webcasts

To access the live webcasts for the two investor conferences, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcasts will be available shortly following the presentation and will remain available for at least 90 days.

About Cepheid

Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.

SOURCE Cepheid